# EDGAR Filing Document

**Accession Number:** 0001635077
**File Stem:** 0001683168-25-005246
**Filing Date:** 2025-7
**Character Count:** 6026
**Document Hash:** 687fcd3ea6ab3be31e2166a98a27bf77
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-005246.hdr.sgml**: 20250721

**ACCESSION NUMBER**: 0001683168-25-005246

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250721

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250721

**DATE AS OF CHANGE**: 20250721

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aclarion, Inc.
- **CENTRAL INDEX KEY:** 0001635077
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 473324725
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41358
- **FILM NUMBER:** 251137273

**BUSINESS ADDRESS:**
- **STREET 1:** 8181 ARISTA PLACE
- **STREET 2:** STE 100
- **CITY:** BROOMFIELD
- **STATE:** CO
- **ZIP:** 80021
- **BUSINESS PHONE:** 833 275 2266

**MAIL ADDRESS:**
- **STREET 1:** 8181 ARISTA PLACE
- **STREET 2:** STE 100
- **CITY:** BROOMFIELD
- **STATE:** CO
- **ZIP:** 80021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Nocimed, Inc.
- **DATE OF NAME CHANGE:** 20150226

?xml version='1.0' encoding='ASCII'? Aclarion, Inc. 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **July 21, 2025**

**Aclarion, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41358** | **47-3324725** |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |

---

---

| | |
|:---|:---|
| **8181 Arista Place, Suite 100** |  |
| **Broomfield, Colorado** | **80021** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(833) 275-2266**

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| <br>**Title of each class** | **Trading**<br>**Symbol(s)** | <br>**Name of each exchange on which registered** |
| Common Stock | ACON | Nasdaq Stock Market |
| Common Stock Warrants | ACONW | Nasdaq Stock Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 5.07** | **Submission of Matters to a Vote of Security Holders.** |

---

On July 21, 2025, the Company reconvened and held its 2025 Annual Meeting of Stockholders. The Annual Meeting had been adjourned from the original scheduled meeting date of July 7, 2025.

The matters voted upon at the Annual Meeting and the results of such voting are set forth below.

**Proposal 1 - Election of seven directors to serve a term ending at the 2026 annual meeting, in each case until their respective successors are duly elected and qualified.**

---

| | | | |
|:---|:---|:---|:---|
| Nominee | Votes For | Withheld | Broker Non-Votes |
| Jeffrey Thramann | 51347 | 15267 | 200431 |
| Brent Ness | 47840 | 18774 | 200431 |
| Stephen Deitsch | 47374 | 19240 | 200431 |
| Scott Breidbart | 50170 | 16444 | 200431 |
| David Neal | 49956 | 16658 | 200431 |
| William Wesemann | 49902 | 16713 | 200431 |
| Amanda Williams | 50244 | 16370 | 200431 |

---

All seven director nominees were duly elected.

**Proposal 2 - Ratification of appointment of independent registered accounting firm – Haynie & Company**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Votes For | Votes For | Votes Against | Votes Against | Abstain | Abstain | Broker Non-Votes | Broker Non-Votes |
|  | 241005 |  | 23143 |  | 2898 |  | 0 |

---

Proposal 2 was approved.

**Proposal 3 – Approval of a proposed reverse stock split**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Votes For | Votes For | Votes Against | Votes Against | Abstain | Abstain | Broker Non-Votes | Broker Non-Votes |
|  | 177593 |  | 87330 |  | 2124 |  | 0 |

---

Proposal 3 was approved.

**Proposal 4 – Approval of an amendment to our 2022 equity incentive plan**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Votes For | Votes For | Votes Against | Votes Against | Abstain | Abstain | Broker Non-Votes | Broker Non-Votes |
|  | 29621 |  | 35466 |  | 1527 |  | 200431 |

---

Proposal 4 was not approved.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ACLARION, INC.** | **ACLARION, INC.** |
| July 21, 2025 | By: | /s/ John Lorbiecki |
|  | Name: | John Lorbiecki |
|  | Title: | Chief Financial Officer |

---